Active immunization of AScr for prion disorders
US6923964B1 · kind B1 · utility
43Cited by
58References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 1, 2000 |
| Grant date | Aug 2, 2005 |
| Priority date | — |
| Expiry date | Oct 17, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are pharmaceutical compositions and methods for preventing or treating a number of amyloid diseases, including Alzheimer's disease, prion diseases, familial amyloid neuropathies and the like. The pharmaceutical compositions include immunologically reactive amounts of amyloid fibril components, particularly fibril-forming peptides or proteins. Also disclosed are therapeutic compositions and methods which use immune reagents that react with such fibril components.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.